Merifin Capital
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Description
Merifin Capital is a European private investment company focused on traditional and alternative asset classes.
Investor Profile
Merifin Capital has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series D, Series Unknown rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Germany.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series A (25%)
- Series D (17%)
- Series Unknown (17%)
- Series C (17%)
- Private Equity (8%)
- Series E (8%)
- Series B (8%)
Country Focus
- United Kingdom (33%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- United States (25%)
- Germany (17%)
- Italy (17%)
- France (8%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Genetics
- Therapeutics
- Manufacturing
- E-commerce
- Semiconductor
- Electronics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
